Curcumin Therapy in Inflammatory Bowel Disease: A Pilot Study
Curcumin, a natural compound used as a food additive, has been shown to have anti-inflammatory and antioxidant properties in cell culture and animal studies. A pure curcumin preparation was administered in an open label study to five patients with ulcerative proctitis and five with Crohn's disease. All proctitis patients improved, with reductions in concomitant medications in four, and four of five Crohn's disease patients had lowered CDAI scores and sedimentation rates. This encouraging pilot study suggests the need for double-blind placebo-controlled follow-up studies.
Key Wordscurcumin ulcerative proctitis Crohn's disease inflammatory bowel disease
Unable to display preview. Download preview PDF.
- 2.Satoskar RR, Shah SJ, Shenoy SG: Evaluation of anti-inflammatory property of curcumin (diferuloytmethane) in patients with postoperative inflammation. Int J Pharmacol Ther Toxicol 24:651–654, 1986Google Scholar
- 6.Plummer SM, Holloway KA, Manson MM, Munks RJ, Kaptein A, Farrow S, Howells L: Inhibition of cyclo-oxygenase 2 expression in colon cells by the chemopreventive agent curcumin involves inhibition of NF-κB activation via the NIK/IKK signaling complex. Oncogene 18:6013–6020, 1999CrossRefPubMedGoogle Scholar